Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Metastases|HER2-positive Breast Cancer
Interventions: OTHER: Pyrotinib Plus Capecitabine combined with brain radiotherapy
Sponsor: Fudan University